Comparison of Immunohistochemical and Fluorescence In Situ Hybridization Assessment for HER-2/neu Status in Taiwanese Breast Cancer Patients

Objective: Accurate diagnostic assessment of human epidermal growth factor receptor-2 (HER-2) is essential and a prerequisite for appropriate application of the humanized anti-HER-2 monoclonal antibody trastuzumab (Herceptin) to the treatment of patients with breast cancer. Immunohistochemistry (IHC...

Full description

Bibliographic Details
Main Authors: Shou-Jen Kuo, Boris Bao-Tyan Wang, Cheng-Shyong Chang, Tze-Ho Chen, Kun-Tu Yeh, Dong-Jay Lee, Pao-Lun Yin, Ming Chen
Format: Article
Language:English
Published: Elsevier 2007-06-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455907600084